her2 breast cancer: evolution of antibody-drug conjugates
Published 4 years ago • 246 plays • Length 3:36Download video MP4
Download video MP3
Similar videos
-
1:38
dr. hart on antibody-drug conjugates in her2 breast cancer
-
0:57
dr. cobleigh on antibody-drug conjugates in development in her2 breast cancer
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
25:46
antibody drug conjugates present and future applications in breast cancer
-
28:55
part 11 - evolution of antibody drug conjugates in cancer - dr. gail phillips, usa
-
5:30
antibody drug conjugates of trastuzumab for her2 mbc
-
4:14
evo-ed: breast cancer and the her2 gene
-
14:08
her2 amplification and breast cancer part 1
-
3:32
her2dx assay and survival outcomes: an individual-patient level meta-analysis of 2,031 patients ...
-
3:42
antibody drug conjugates in metastatic breast cancer | anthony elias, md | esmo22 colorado
-
2:03
dr. marks on investigational antibody-drug conjugates in her2 breast cancer
-
2:11
next-generation antibody-drug conjugates in her2 breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
2:40
emergence of antibody-drug conjugates in metastatic breast cancer: 2022 esmo florida
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
2:39
dr. diefenbach explains antibody drug conjugates
-
1:11
development of antibody-drug conjugate therapies in breast cancer
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
0:23
next generation her2 targeted therapies: promising advances in cancer treatment